Converting Centrally Authorised Products (CAPs) to UK Marketing Authorisations (MAs), 'grandfathering' and managing lifecycle changes

Name: Converting Centrally Authorised Products (CAPs) to UK Marketing Authorisations (MAs), 'grandfathering' and managing lifecycle changes
Creator: Medicines and Healthcare products Regulatory Agency
License: https://www.nationalarchives.gov.uk/doc/open-government-licence/version/2/
Keywords: centrally-authorised-products,changes,guidances,lifecycle,marketing,medicinal-products,uk

Information

Original link

Type

Guidance

Regulated products

Medical Devices

Topics

Brexit, Health And Social Care

Published

December 31, 2020

Last updated

October 15, 2021

Description

This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.

Organization

Medicines and Healthcare products Regulatory Agency (MHRA) 🇬🇧

Country / Region

United Kingdom

License

Open Government Licence 2.0 (United Kingdom)

Feedback

Suggest an improvement to this page

1 Main file

Converting Centrally Authorised Products (CAPs) to UK Marketing Authorisations (MAs), 'grandfathering' and managing lifecycle changes

Updated on October 15, 2021

html

URL: https://www.gov.uk/guidance/converting-centrally-authorised-products-caps-to-uk-marketing-authorisations-mas-grandfathering-and-managing-lifecycle-changes
Permalink: https://data.openrid.co/en/datasets/r/06b2501b-ce2b-411b-b4f6-191a28c46cd8
MIME Type: text/html

Created on: December 31, 2020
Modified on: October 15, 2021

Converting Centrally Authorised Products (CAPs) to UK Marketing Authorisations (MAs), 'grandfathering' and managing lifecycle changes

Information

Type

Regulated products

Topics

Published

Last updated

Description

Tags

Organization

Country / Region

License

Feedback

Actions

Social networks

Embed